We are excited to share the addition of Dr. Natalie LaFranzo, PhD to the role of Vice President of Strategy to the LINUS leadership team.
Dr. LaFranzo brings strengths in strategic marketing, market development, and communication honed through roles in early stage and mature companies across the life sciences. Her clinical experience has focused on bringing industry-changing diagnostic and genomic technologies to the competitive oncology market. Prior to joining LINUS, she most recently served as the Director of Marketing Communications at Personalis. She also served as Vice President of Market Development at Cofactor Genomics, and held roles at Horizon Discovery and Red Rock Laboratories after completing her PhD in Chemistry at Washington University in St. Louis. In 2021, Natalie was elected to the Board of Directors of the American Chemical Society, one of the world’s largest scientific organizations with a mission to advance the broader chemistry enterprise and its practitioners for the benefit of Earth and its people.
“Natalie brings a unique background of executive and board experience, combined with technical and marketing acumen to her role at LINUS,” stated Founder and CEO Hamid Ghanadan. “I’m thrilled for the value this brings to the client organizations and teams we support.”
As Vice President, Natalie will champion LINUS’ proven frameworks and fundamentals in human behavior and heuristics to develop strategies and insights that create unprecedented growth opportunities for clients.
“The companies we work with are challenging the status quo in healthcare, and to be able to provide them with the data, insights, and strategies they need to succeed is energizing,” said LaFranzo. “There is natural alignment between LINUS’ vision, values, and approach to my own personal and professional goals. This role is a natural fit and an incredible opportunity to directly impact the translation of innovation to global precision health.”
The LINUS team offers strategy consulting to address all aspects of commercialization in science, technology, healthcare and has recently launched a unique strategy activation offering – Strategy Sprint Sessions – in response to the dynamic economic climate.